Skip to Main Content

Advertisement

Skip Nav Destination

Abstract P4-15-04: Neoadjuvant endocrine therapy for ER+ DCIS can lead to disease regression and allows BCS in up to a third of patients with disease >40mm at diagnosis

Cancer Res (2019) 79 (4_Supplement): P4-15-04.
Currently there are no citedby results. Try again later.
Close Modal

or Create an Account

Close Modal
Close Modal